UDC 61

PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)

Published in Acta biomedica scientifica · Volume 2, Issue 2 · Pages 14–17 · Rubric: Clinical Medicine
DOI: https://doi.org/10.12737/article_59a614f6883957.55938557
Received: 11.08.2017 Accepted: 24.03.2024
Izucheny psihoticheskie rasstroystva u lic, upotreblyayuschih sinteticheskie kannabinoidy (spaysy): shizofrenopodobnoe rasstroystvo (60 %), intoksikacionnyy deliriy (35 %), psihoticheskoe rasstroystvo s preimuschestvenno maniakal'nymi simptomami (5 %). Sredi pacientov s shizofrenopodobnym rasstroystvom dlitel'nost'yu do 1 mesyaca vydeleny sluchai psihozov s monomorfnoy i polimorfnoy klinicheskoy kartinoy. Shizofrenopodobnye psihozy dlitel'nost'yu techeniya bolee 1 mesyaca trebuyut differencial'noy diagnostiki s manifestnym pristupom shizofrenii ili shizoaffektivnym rasstroystvom.
ostrye psihozy, sinteticheskie kannabinoidy (spaysy)
Text References
Text (PDF)
Read Download

1. Kaklyugin NV. (2014). Modern types of narcotic substances and psychotropic agent, and psychosocial consequences of their consumption [Sovremennye vidy narkoticheskikh sredstv i psikhotropnykh preparatov i psikhosotsial’nye posledstviya ikh potrebleniya]. Psikhicheskoe zdorov’e, (2), 73-99.

2. Kudril NV. (2015). Topical issues of toxicology and laboratory identification of synthetic cannabinoids (prepared according to the data of European Monitoring Centre for Drugs and Drug Addiction - EMCDDA) [Aktual’nye voprosy toksikologii i laboratornoy identifikatsii sinteticheskikh kannabinoidov (podgotovleno po materialam Evropeyskogo tsentra monitoringa narkotikov i narkomanii - EMCDDA)]. Meditsina neotlozhnykh sostoyaniy, (2), 10-18.

3. Mendelevich VD. (2014). Psychotic disorders due to drug use: state of the art [Psikhoticheskie rasstroistva v rezul’tate upotrebleniya narkotikov: sovremennoe sostoyanie problem]. Narkologiya, (7), 93-100.

4. ICD-10: Classification of mental and behavioral disorders (clinical descriptions and instructions) (1994) [MKB-10: Klassifikatsiya psikhicheskikh i povedencheskikh rasstroistv (klinicheskie opisaniya i ukazaniya po diagnostike)]. Sankt-Peterburg, 300 p.

5. Ivanets NN (ed.). (2008). Guidelines on narcology [Rukovodstvo po narkologii]. Moskva, 944 p.

6. Sofronov GA, Golovko AI. (2012). Synthetic cannabinoids [Sinteticheskie kannabinoidy]. Narkologiya, (10), 97-110.

7. Khoroshilov GP, Khudyakov AV. (2015). Induced psychotic disorders associated with modern psychoactive substances use [Intoksikatsionnye psikhozy, svyazannye s upotrebleniem sovremennykh psikhoaktivnykh veshchestv]. Prakticheskaya meditsina, (5), 7-10.

8. Chukhrova MG, Pronin SV, Rybalchuk NV, Ivanova VE. (2015). Psychological and psychosomatic effects of spice consumption [Psikhicheskie i psikhosomaticheskie posledstviya potrebleniya spaysov]. Mir nauki, kul’tury, obrazovaniya, (1), 423-426.

9. Fergusson DM. (2004). Cannabis and psychosis accumulating evidence. Addiction, 99 (10), 1351-1352.

10. Fergusson DM, Boden JM, Horwood LJ. (2006). Cannabis use and other illicit drug use. Testing the cannabis gateway hypothesis. Addiction, 101 (4), 556-569.

11. Niemi-Pynttari JA, Sund R., Putkonen H. (2013). Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. J. Clin. Psychiatry, 74 (1), 94-95.